• The 8-week programme offers in person training from industry leaders to build strong business foundations and prepare for investment 

• Finalists have the chance to win a business support package worth over £100,000, including one year of free lab space at Discovery Park and £50,000 investment from Discovery Park Ventures 

• The winner will be announced at the GIANT Health conference on 5th December 2023 

Sandwich, UK, 27th September 2023 / Sciad Newswire / Discovery Park / Thirteen life science start-ups have been accepted onto Discovery Park’s new business support programme and competition, Discovery Spark.  The eight-week Discovery Spark programme will equip the early-stage companies with the necessary skills to catalyse their business growth plans and gives them the chance to win a business support package worth over £100,000. 

The start-ups span across the biotech, digital tech, engineering biology, synthetic biology and medical technology sectors. Participants were chosen by a judging panel that scored the start-ups based on their product or service, opportunity and market, team management, programme fit and investment potential. Taking part in the programme will be 3D Synthesis, Awen, Bing Bong Biologics, BioMavericks, BugBiome, CardioCrown, DLOC Biosystems, Dravya Discovery, KASNMR, Matrix Bio, Rapidx Bio, The Future Care and XR-Musica.  

As part of the programme, Discovery Park will host in-person training sessions, covering topics such as building an excellent team, understanding and conveying business metrics, and branding. The start-ups will also be able to take advantage of opportunities for networking, mentoring, learning from shared experiences and perfecting their investor pitch. The programme will culminate with an investor pitching event sponsored by Discovery Park as part of the GIANT Health conference on 5th December 2023. The start-up with the best pitch at the conference will win a business support package worth over £100,000. The package includes one free year of lab space at Discovery Park and £50,000 investment from Discovery Park Ventures, as well as comprehensive business support and mentoring. 

Discovery Park’s Head of Innovation, Renos Savva, is leading the programme, bringing extensive experience in science entrepreneurship including co-founding Domainex and providing training for life science audiences across academia and industry. He said: “We were overwhelmed by the number of applications for Discovery Spark. The start-ups selected show phenomenal potential and we’re excited to accelerate their growth. Being investor-ready is essential for start-ups and Discovery Spark ensures participants will have the best team, brand image and business know-how by the end of the programme.” 

BugBiome is harnessing the power of the skin microbiome to repel mosquitoes. Most mosquito repellents on the market provide protection for just a few hours and contain persistent synthetic chemicals that can harm the environment. BugBiome aims to utilise natural bacteria that repel mosquitos to create an effective and safe solution. Alicia Showering, Founder and CEO at BugBiome, said: “We’re passionate about stopping the spread of deadly vector-borne diseases like malaria and Dengue by bringing longer-lasting natural repellents to market. Taking part in Discovery Spark will give us the necessary business tools to make this a reality.”  

Delayed diagnosis of microbial diseases leads 15 million avoidable deaths every year. RapidX has developed a disease detection technology to deliver point of care diagnosis in under 30 minutes. Its technology doesn’t require specialist training to use and has important implications for the targeted treatment of diseases which will be vital to combat microbial drug resistance.  

CardioCrown develops MedTech devices that empower stroke rehabilitation at home. Its integrated rehabilitation technology incorporates virtual reality, functional electrical stimulation and artificial intelligence to help accelerate the recovery of stroke patients. The engaging product will also reduce the time clinicians will have to spend with patients and help stroke units streamline processes. 

Mayer Schreiber, CEO at Discovery Park, commented: “Not only will participants receive business training fine-tuned to life-science start-ups, but also access to Discovery Park’s cutting-edge facilities, where they will have the opportunity to network, ideate and collaborate. Discovery Park is committed to supporting the next generation of life science leaders, and our Discovery Spark programme embodies that.” 

ENDS 

For further information, please contact: 

Kirsty Budden 
Head of Marketing, Discovery Park 
E: kirsty.budden@discovery-park.co.uk
T: +44 (0) 7730 618514  

Sciad Communications, Media Relations  
Juliette Craggs / Jasmin Shearan 
E: pressteam@sciad.com 
T: +44 (0)20 3405 7892  

Notes for Editors 

About Discovery Park  

Discovery Park is a thriving life science community for visionary entrepreneurs and leaders and the ideal environment for businesses to start, scale and succeed. We offer state-of-the-art labs, modern offices and manufacturing facilities, unrivalled flexibility and comprehensive support including access to finance and a strong local talent pool. Within easy reach of London, Discovery Park spearheads Kent’s flourishing science and technology cluster. As an extension of the Golden Triangle, our location provides access to a wealth of resources and opportunities coupled with an enviable quality of life.  

 Discovery Park is home to 160+ companies employing around 3,100 people across a growing tenant community of dynamic start-ups through to global corporations. This includes Pfizer, which built the site’s reputation as a centre for drug discovery and discovered some of the most famous drugs in the world here. Pfizer still play a key role in the community, occupying a third of the site and employing over 1,000 scientists, technicians, regulatory professionals and business experts. Other tenants include Algaecytes, Canterbury Christ Church University, Concept Life Sciences, eXroid, Genea Biomedx, LGC, Viatris, Psyros Diagnostics, Salvensis, VisusNano and Wren Healthcare.   

Discover more via our website: www.discovery-park.co.uk email: info@discovery-park.co.uk or call: 01304 614060. You can also follow us on social media: LinkedIn, X , Facebook.